Article Type
Changed
Mon, 03/13/2023 - 18:09

Key clinical point: Prepregnancy migraine history was associated with a higher risk for adverse pregnancy outcomes, including preterm delivery, preeclampsia, and gestational hypertension.

 

Major finding: Participants with vs without a history of prepregnancy migraine were at a 17% increased risk for preterm delivery (adjusted relative risk [aRR] 1.17; 95% CI 1.05-1.30), 28% higher risk for gestational hypertension (aRR 1.28; 95% CI 1.11-1.48), and 40% greater risk for preeclampsia (aRR 1.40; 95% CI 1.19-1.65).

 

Study details: This prospective cohort study evaluated 30,555 incident pregnancies in 19,694 participants, of which 11.3% of participants reported a history of physician-diagnosed migraine with or without aura.

 

Disclosures: This study was supported by the US National Institutes of Health (NIH). Six authors declared receiving support from NIH unrelated to this study and reported ties with various sources.

 

Source: Purdue-Smithe AC et al. Prepregnancy migraine, migraine phenotype, and risk of adverse pregnancy outcomes. Neurology. 2023 (Jan 19). Doi: 10.1212/WNL.0000000000206831

Publications
Topics
Sections

Key clinical point: Prepregnancy migraine history was associated with a higher risk for adverse pregnancy outcomes, including preterm delivery, preeclampsia, and gestational hypertension.

 

Major finding: Participants with vs without a history of prepregnancy migraine were at a 17% increased risk for preterm delivery (adjusted relative risk [aRR] 1.17; 95% CI 1.05-1.30), 28% higher risk for gestational hypertension (aRR 1.28; 95% CI 1.11-1.48), and 40% greater risk for preeclampsia (aRR 1.40; 95% CI 1.19-1.65).

 

Study details: This prospective cohort study evaluated 30,555 incident pregnancies in 19,694 participants, of which 11.3% of participants reported a history of physician-diagnosed migraine with or without aura.

 

Disclosures: This study was supported by the US National Institutes of Health (NIH). Six authors declared receiving support from NIH unrelated to this study and reported ties with various sources.

 

Source: Purdue-Smithe AC et al. Prepregnancy migraine, migraine phenotype, and risk of adverse pregnancy outcomes. Neurology. 2023 (Jan 19). Doi: 10.1212/WNL.0000000000206831

Key clinical point: Prepregnancy migraine history was associated with a higher risk for adverse pregnancy outcomes, including preterm delivery, preeclampsia, and gestational hypertension.

 

Major finding: Participants with vs without a history of prepregnancy migraine were at a 17% increased risk for preterm delivery (adjusted relative risk [aRR] 1.17; 95% CI 1.05-1.30), 28% higher risk for gestational hypertension (aRR 1.28; 95% CI 1.11-1.48), and 40% greater risk for preeclampsia (aRR 1.40; 95% CI 1.19-1.65).

 

Study details: This prospective cohort study evaluated 30,555 incident pregnancies in 19,694 participants, of which 11.3% of participants reported a history of physician-diagnosed migraine with or without aura.

 

Disclosures: This study was supported by the US National Institutes of Health (NIH). Six authors declared receiving support from NIH unrelated to this study and reported ties with various sources.

 

Source: Purdue-Smithe AC et al. Prepregnancy migraine, migraine phenotype, and risk of adverse pregnancy outcomes. Neurology. 2023 (Jan 19). Doi: 10.1212/WNL.0000000000206831

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Migraine, March 2023
Gate On Date
Thu, 02/24/2022 - 16:45
Un-Gate On Date
Thu, 02/24/2022 - 16:45
Use ProPublica
CFC Schedule Remove Status
Thu, 02/24/2022 - 16:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article